Source: Annual Congress 2013 –Treatment of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Barthwal, V. Dutta, P. Bhattacharya, A. Vora, M. Kotnis (Indore, Chandigarh, Kolkotta, Mumbai, India). Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level. Eur Respir J 2013; 42: Suppl. 57, 915

Member's Comments

No comment yet.

Related content which might interest you: Outcomes with omalizumab in Indian patients with allergic (IgE-mediated) asthma: Results at 16 and 28 weeks Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study Source: International Congress 2016 – Asthma points to ponder Year: 2016 Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes Source: International Congress 2016 – Airway stenting and ablation Year: 2016 X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients Source: International Congress 2016 – Asthma management Year: 2016 The control of asthma in real life: Baseline evaluation of a long-term study Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Health related quality of life in asthmatic subjects after 3 months treatment with inhaled corticosteroids Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 The impact of the addition of omalizumab on the utilization of healthcare resources by severe persistent asthma patients Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Fluticasone propionate/formoterol therapy for asthmatic patients: Results of a non-interventional study Source: International Congress 2016 – Asthma management Year: 2016 Effects of allergic rhinitis on self-management and quality of life in adult patients with asthma Source: International Congress 2014 – From individual patient interactions to models of care: the nursing perspective Year: 2014 Effectiveness of montelukast on asthma control in infants: A claims data study Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Asthma control, symptoms and exacerbations across treatment levels in patients with asthma Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013 Comparison of asthma control tests with quality of life in childhood asthma Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013 Real life experience of omalizumab on selected children with severe allergic asthma Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 Total and free IgE in evolution of severe asthma after omalizumab treatment Source: International Congress 2016 – Asthma management Year: 2016 Real life effectiveness of omalizumab in severe allergic asthma, does the IgE level matter? A Bradford experience Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Metrics of salbutamol use as predictors of future adverse outcomes in asthma Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013